Curio Bioscience Announces Early Access to the World’s First Product to Transform Single-Cell Sequencing Data into Spatial Context
The first stage of Curio’s commercialization of this new product, called Curio Trekker, is an early access program that already includes world-class research organizations as participants.
- The first stage of Curio’s commercialization of this new product, called Curio Trekker, is an early access program that already includes world-class research organizations as participants.
- “Curio Trekker is the world’s first product that converts single-cell genomics data into single-cell spatial data, enabling a new era of scientific discovery that is simply not possible with today’s standard single-cell sequencing workflows,” said Christina Fan, PhD, Co-founder and CTO of Curio Bioscience.
- Curio Bioscience has signed a licensing agreement with the Broad Institute, Inc. and is commercializing the technology.
- “Curio Trekker is the culmination of this work and provides the spatial context that single-cell researchers are lacking today in a readily accessible format.